Twist Bioscience Corporation reported earnings results for the fourth quarter ended September 30, 2023. For the fourth quarter, the company reported sales was USD 66.95 million compared to USD 57.31 million a year ago. Net loss was USD 46.24 million compared to USD 51.12 million a year ago.

Basic loss per share from continuing operations was USD 0.81 compared to USD 0.91 a year ago.